Nivolumab,Paclitaxel,Carboplatin
bms
['lcsm,(-blcsm)']
the greatest changes in the immune expression profile during neoadjuvant chemo-inmmunotherapy treatment were observed in pcr tumors reflecting an active
immune response. #esmo22 #lcsm 
Associate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Head of Thoracic Oncology & Clinical Trials. Professor of Oncology Universidad Autónoma Madrid Spain